GlaxoSmithKline plc
Pharmaceuticals
Company Summary
GlaxoSmithKline plc, through its subsidiaries, develops, manufactures, and markets pharmaceuticals, vaccines, over-the-counter medicines, and health-related consumer items in the United Kingdom, the United States, and globally. Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare are the company's four segments. GlaxoSmithKline plc is based in Brentford, United Kingdom, and was founded in 1715.
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
29.7
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Refinitiv
Overall ESG Rating :
94
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
AA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
GSK is a leader among 80 companies in the pharmaceuticals industry.
Temperature Rise :
1.3℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
